CogState signs $400,000 functional food deal
Monday, 13 February, 2006
CogState (ASX:CGS) is to provide cognition testing services to a European food products company in a contract worth more than AUD$400,000.
Over the next 12 to 15 months, Cogstate will be studying the effect of the European company's dietary product on cognitive function in a trial conducted at the Murdoch Children's Research Institute, Melbourne.
If the trial demonstrates cognitive function enhancement as a result of people consuming its dietary supplement, the food products company will be able to make marketing claims in relation to the product.
Personalised melanoma vaccine cuts risk of recurrence
Adding a personalised, mRNA-based cancer vaccine to standard immunotherapy after surgery for...
Research project to produce fish-free omega-3
SCU researchers are investigating how to grow omega-3-producing microorganisms more cheaply...
Biodegradable smart patch can detect and treat blood clots
Researchers have developed a biodegradable smart patch that detects pressure changes and releases...
